483 Nesher Pharmaceuticals (USA) Apr 2003

483 Nesher Pharmaceuticals (USA) Apr 2003

Karen Daugherty FDA$119.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 29 Apr 2003.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Apr 2003
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart